EXTH-29. INHIBITION OF LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A (KDM1A/LSD1) SENSITIZES GLIOBLASTOMA CELLS TO CHEMO AND RADIATION THERAPY

BACKGROUND: Despite treatment advances, glioblastoma (GBM) is the deadliest tumor of the central nervous system. Patients face a dismal 15-month median survival and average 5-year survival rate of 13%. Current standard of care includes surgical resection, external beam radiation therapy, and adjuvan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Alejo, Salvador, Palacios, Bridgitte, Venkata, Prabhakar Pitta, Chen, Yihong, He, Yi, Viswanadhapalli, Suryavathi, Pratap, Uday, Zheng, Siyuan, Brenner, Andrew, Vadlamudi, Ratna, Sareddy, Gangadhara
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Preclinical Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651145/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.383
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados